A Single Arm Phase 2 Study to Evaluate the Safety and Efficacy of Nab-Paclitaxel in Subjects With Previously Treated Metastatic Colorectal Cancer

Trial Profile

A Single Arm Phase 2 Study to Evaluate the Safety and Efficacy of Nab-Paclitaxel in Subjects With Previously Treated Metastatic Colorectal Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jan 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Sponsors Celgene Corporation
  • Most Recent Events

    • 19 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 09 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 09 Dec 2014 Planned End Date changed from 1 Feb 2016 to 1 Jan 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top